About Us
Asia Air WatchLive PM2.5 Medical Alerts
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Cluster analysis of high-cost patients in Japan: A longitudinal study using health insurance data.

Researchers

Yoko Matsuo, Keita Yamauchi

Abstract

This study aimed to identify distinct patterns of medical expenditure trajectories among high-cost patients in Japan and characterise the identified groups using diagnostic and health check-up data, including laboratory test results. This retrospective study analysed data from 190,190 high-cost patients (top 5% of annual medical expenditure in fiscal year 2021) in the Japanese JMDC Claims Database. Five-year healthcare expenditure trajectories were classified using K-means clustering. The resulting clusters were characterised according to demographic characteristics, disease patterns, hospitalisation rates, and health check-up data. Eighteen clusters were identified and further grouped into four descriptive types of expenditure trajectory. The 'over-30-million-yen (200,000 USD)' type included two clusters with rare, high-cost diseases such as haematological disorders, chronic viral hepatitis, and sphingolipid metabolism disorders. The 'flat' type (four clusters) showed relatively smooth expenditure patterns over time, associated with chronic conditions like dialysis and secondary cancers. In contrast, the 'gradual peak' type exhibited costs that increased over time, largely due to malignant neoplasms. Meanwhile, the 'sharp peak' type was characterised by sudden cost surges driven primarily by inpatient care, with a high prevalence of angina and atrial fibrillation. By analysing five-year expenditure trajectories at the individual level, this study identified distinct longitudinal patterns and provided a descriptive framework for understanding heterogeneity among high-cost patients.
Source: PubMed (PMID: 43050460)View Original on PubMed